HIL12R1.2B10 [HIL12R1.2B10.C5.D11]
HIL12R1.2B10 [HIL12R1.2B10.C5.D11]
规格:
货期:
编号:TS212006
品牌:Testobio
| 产品名称： | HIL12R1.2B10 HIL12R1.2B10.C5.D11 |
|---|---|
| 商品货号： | TS212006 |
| Organism： | Rattus norvegicus (B cell); Mus musculus (myeloma), rat (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The hybridoma cell line HIL12R1.2B10 HIL12R1.2B10.C5.D11 was established by David Presky and Lisa Mondini-Minetti in 1994 and subcloned twice. The antibody is a useful tool for detection of huIL-12Rbeta1 by flow cytometry, Western Blot analysis and immunoprecipitation. |
| Derivation： | The hybridoma cell line HIL12R1.2B10 HIL12R1.2B10.C5.D11 was established by David Presky and Lisa Mondini-Minetti in 1994 and subcloned twice. |
| Clinical Data： | HIL12R1.2B10 was formed by the fusion of SP2/0 mouse myeloma cells with splenocytes from an adult female Lewis rat inoculated with transfected COS-7 cells expressing huIL-12Rbeta1. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human interleukin 12 (IL-12) receptor beta1 (huIL-12Rbeta1) subunit |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human interleukin 12 (IL-12) receptor beta1 (huIL-12Rbeta1) subunit |
| Comments： | The hybridoma cell line HIL12R1.2B10 HIL12R1.2B10.C5.D11 was established by David Presky and Lisa Mondini-Minetti in 1994 and subcloned twice. The antibody is a useful tool for detection of huIL-12Rbeta1 by flow cytometry, Western Blot analysis and immunoprecipitation. HIL12R1.2B10 was formed by the fusion of SP2/0 mouse myeloma cells with splenocytes from an adult female Lewis rat inoculated with transfected COS-7 cells expressing huIL-12Rbeta1. |
| Complete Growth Medium： | Iscoves Modified Dulbeccos Medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate supplemented with 0.05 mM 2-mercaptoethanol and 100 U/ml recombinant human IL-6, 90%; fetal bovine serum, 10%.
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Alternately, cultures can be established by centrifugation with subsequent resuspension in fresh culture medium. Establish new cultures at 2 X 10 exp5 viable cells/ml and maintain at between 1 X 10 exp5 and 1 X 10 exp6 viable cells/ml. |
| Cryopreservation： | Culture medium, 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C |
| Isotype： | IgG2a |
| Name of Depositor： | DH Presky |
| Year of Origin： | 1994 |
| References： | Wu CY, et al. Biological function and distribution of human interleukin-12 receptor beta chain. Eur. J. Immunol. 26: 345-350, 1996. PubMed: 8617302 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
HIL12R1.2B10 [HIL12R1.2B10.C5.D11]
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | HIL12R1.2B10 HIL12R1.2B10.C5.D11 |
|---|---|
| 商品货号： | TS212006 |
| Organism： | Rattus norvegicus (B cell); Mus musculus (myeloma), rat (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The hybridoma cell line HIL12R1.2B10 HIL12R1.2B10.C5.D11 was established by David Presky and Lisa Mondini-Minetti in 1994 and subcloned twice. The antibody is a useful tool for detection of huIL-12Rbeta1 by flow cytometry, Western Blot analysis and immunoprecipitation. |
| Derivation： | The hybridoma cell line HIL12R1.2B10 HIL12R1.2B10.C5.D11 was established by David Presky and Lisa Mondini-Minetti in 1994 and subcloned twice. |
| Clinical Data： | HIL12R1.2B10 was formed by the fusion of SP2/0 mouse myeloma cells with splenocytes from an adult female Lewis rat inoculated with transfected COS-7 cells expressing huIL-12Rbeta1. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human interleukin 12 (IL-12) receptor beta1 (huIL-12Rbeta1) subunit |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human interleukin 12 (IL-12) receptor beta1 (huIL-12Rbeta1) subunit |
| Comments： | The hybridoma cell line HIL12R1.2B10 HIL12R1.2B10.C5.D11 was established by David Presky and Lisa Mondini-Minetti in 1994 and subcloned twice. The antibody is a useful tool for detection of huIL-12Rbeta1 by flow cytometry, Western Blot analysis and immunoprecipitation. HIL12R1.2B10 was formed by the fusion of SP2/0 mouse myeloma cells with splenocytes from an adult female Lewis rat inoculated with transfected COS-7 cells expressing huIL-12Rbeta1. |
| Complete Growth Medium： | Iscoves Modified Dulbeccos Medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate supplemented with 0.05 mM 2-mercaptoethanol and 100 U/ml recombinant human IL-6, 90%; fetal bovine serum, 10%.
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Alternately, cultures can be established by centrifugation with subsequent resuspension in fresh culture medium. Establish new cultures at 2 X 10 exp5 viable cells/ml and maintain at between 1 X 10 exp5 and 1 X 10 exp6 viable cells/ml. |
| Cryopreservation： | Culture medium, 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C |
| Isotype： | IgG2a |
| Name of Depositor： | DH Presky |
| Year of Origin： | 1994 |
| References： | Wu CY, et al. Biological function and distribution of human interleukin-12 receptor beta chain. Eur. J. Immunol. 26: 345-350, 1996. PubMed: 8617302 |
